Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs
Author:
Funder
Institute of Pharmaceutical Research, GLA University, Mathura
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference68 articles.
1. Drug repurposing for breast cancer therapy: old weapon for new battle;Aggarwal;Semin. Cancer Biol.,2019
2. 2018. Clinical and molecular aspects of breast cancer: targets and therapies;Godone;Biomed. Pharmacother.,2018
3. An update on randomized clinical trials in breast cancer;Barnard;Surg. Oncol. Clin. N. Am.,2017
4. Formulation and characterization of polyphenol-loaded lipid nanocapsules;Barras;Int. J. Pharm.,2009
5. Breast cancer: biology, biomarkers, and treatments;Barzaman;Int. Immunopharmacol.,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Andrographis paniculata and Andrographolide - A Snapshot on Recent Advances in Nano Drug Delivery Systems against Cancer;Current Drug Delivery;2024-06
2. New insights into therapeutic applications and nanoformulation approaches of hesperidin: An updated review;Pharmacological Research - Modern Chinese Medicine;2024-03
3. In vitro evaluation of dioscin and protodioscin against ER-positive and triple-negative breast cancer;PLOS ONE;2023-02-09
4. DNA Nanobots – Emerging Customized Nanomedicine in Oncology;Current Drug Delivery;2023-02
5. Development and optimization of nanoemulsion containing exemestane using box-behnken design;Journal of Drug Delivery Science and Technology;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3